Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
41°
Clear
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Fate Therapeutics
(NQ:
FATE
)
4.060
-0.040 (-0.98%)
Official Closing Price
Updated: 4:15 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Fate Therapeutics
< Previous
1
2
3
4
5
Next >
Where Fate Therapeutics Stands With Analysts
April 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 10, 2024
Via
Benzinga
Evaluating Fate Therapeutics: Insights From 5 Financial Analysts
March 19, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Fate Therapeutics
February 27, 2024
Via
Benzinga
Domino's To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Tuesday
February 27, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Recap: Fate Therapeutics Q4 Earnings
February 26, 2024
Via
Benzinga
A Preview Of Fate Therapeutics's Earnings
February 23, 2024
Via
Benzinga
Analyst Ratings for Fate Therapeutics
November 09, 2023
Via
Benzinga
Recap: Fate Therapeutics Q3 Earnings
November 08, 2023
Via
Benzinga
Earnings Scheduled For February 26, 2024
February 26, 2024
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million.
Via
Benzinga
Analyst Ratings for Fate Therapeutics
September 07, 2023
Via
Benzinga
The Latest Analyst Ratings for Fate Therapeutics
August 16, 2023
Via
Benzinga
Where Fate Therapeutics Stands With Analysts
May 05, 2023
Via
Benzinga
Billionaire Steve Cohen Is Betting Big on Fate Therapeutics (FATE) Stock
January 29, 2024
Billionaire Steve Cohen is taking a massive stake in this little-known biotech company, leading FATE stock to surge more than 17%.
Via
InvestorPlace
Pinstripes, SoFi Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
January 03, 2024
U.S. stock futures were lower this morning, with the Dow Jones futures falling around 60 points on Wednesday. Shares of Pinstripes (NYSE: PNST) shares fell in pre-market trading after surging 22% on...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 12, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 01, 2023
On Tuesday, 46 stocks hit new 52-week lows.
Via
Benzinga
Fate Therapeutics: Q1 Earnings Insights
May 03, 2023
Via
Benzinga
Fate Therapeutics Earnings Preview
May 02, 2023
Via
Benzinga
Why Shares of Fate Therapeutics Soared This Week
June 16, 2023
The company's shares bounced back after a stock sale last week.
Via
The Motley Fool
$1.7M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
April 24, 2023
Although US stocks closed slightly higher on Friday, there were a few notable insider trades.
Via
Benzinga
15 Analysts Have This to Say About Fate Therapeutics
March 27, 2023
Via
Benzinga
Expert Ratings for Fate Therapeutics
March 01, 2023
Via
Benzinga
Outset Medical, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
February 14, 2023
Don’t forget to check out our premarket coverage here Fate Therapeutics, Inc. (NASDAQ: FATE) fell 4.1% to $6.13 in pre-market trading. Fate Therapeutics is expected to report Q4 results on Tuesday,...
Via
Benzinga
Sorrento Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
February 13, 2023
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Analyst Ratings for Fate Therapeutics
January 24, 2023
Via
Benzinga
5 Cheapest Health Care Stocks You Should Think About
January 27, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 24, 2023
January 24, 2023
Via
Benzinga
5 Health Care Stocks That Are Diving - And May Rally
January 19, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Over $10 Million Bet On DiamondHead Holdings? Check Out These 4 Stocks Insiders Are Buying
January 17, 2023
Although US stocks closed higher on Friday, there were a few notable insider trades.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.